Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Immunology | Hepatology (Liver, Pancreatic, Gall Bladder) | Infections and Infectious Diseases | Vaccines

Hepatitis Clinical Trials

A listing of Hepatitis medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last 

Alabama

University of Alabama at Birmingham
Birmingham Alabama 35294

A Phase 2 clinical study for patients with Acute on Chronic Hepatic Failure, Acute Liver Failure, Liver Cirrhosis or Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 95592
Birmingham Alabama 35294

A Phase 3 clinical study for patients with Hepatitis C, HIV Infection, Chronic Hepatitis C or Compensated Cirrhosis and Non-cirrhotics

Call for Information (Investigational Site 0413)
Birmingham Alabama 35294

Patients are needed to participate in a clinical research study evaluating MK-5172 100mg/MK-8742 50 mg fixed-dose combination and Placebo to MK-5172 + MK-8742 fixed-dose combination for the treatment of Chronic Hepatitis C Virus

Site Reference ID/Investigator# 103551
Birmingham Alabama 35215

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Clinical Research Advantage, Inc.
Birmingham Alabama 35211

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

View More »

Site Reference ID/Investigator# 124035
Dothan Alabama 36305

A clinical trial to evaluate treatments using ABT-450/r, ABT-530 and Ribavirin (RBV) for patients with Chronic Hepatitis C or Hepatitis C Virus

Site Reference ID/Investigator# 103531
Dothan Alabama 36305

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Arizona

Clinical Research Advantage, Inc.
Chandler Arizona 85224

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Radiant Research
Chandler Arizona 85224

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Glendale Arizona 85306

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Mesa Arizona 85213

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Mesa Arizona 85206

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

View More »

Phoenix Arizona
Updated

A clinical research study of SOF/GS-5816 and RBV for the treatment of Hepatitis C Virus Infection

Maricopa Integrated Health System (MIHS)
Phoenix Arizona 85008
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Phoenix Arizona

A clinical trial to evaluate treatments using Telaprevir, Peginterferon alfa-2b and Ribavirin for patients with Hepatitis C

Spectrum Medical Group
Phoenix Arizona 85012

A Phase 3 clinical study for patients with HIV or HBV

Phoenix Children's Hospital
Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Tenofovir DF and Tenofovir DF Placebo for the treatment of Chronic Hepatitis B Infection

Site Reference ID/Investigator# 106155
Phoenix Arizona 85054

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Phoenix Arizona
Updated

Patients are needed to participate in a clinical research study of No intervention to evaluate Hepatitis C Virus

Clinical Research Advantage, Inc.
Phoenix Arizona 85018

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Phoenix Arizona 85020

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Phoenix Arizona 85050

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Radiant Research
Scottsdale Arizona 85251

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Tempe Arizona 85283

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

University of Arizona Medical Center
Tucson Arizona 85724
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 95581
Tucson Arizona 85724-5136

A Phase 3 clinical study for patients with Hepatitis C, HIV Infection, Chronic Hepatitis C or Compensated Cirrhosis and Non-cirrhotics

Site Reference ID/Investigator# 106055
Tucson Arizona 85724

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Radiant Research
Tucson Arizona 85712

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

Clinical Research Advantage, Inc.
Tucson Arizona 85741

Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine

GSK Investigational Site
Tucson Arizona 85741

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Arkansas

GSK Investigational Site
Fayetteville Arkansas 72703

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

University of Arkansas for Medical Sciences
Little Rock Arkansas 72205
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Arkansas Gastroenterology
North Little Rock Arkansas 72117
Updated

Patients are needed to participate in a clinical research study to evaluate Hepatitis C

California

Anaheim Clinical Trials (ACT)
Anaheim California 92801

Hepatitis C research study for Latino and non-Latino patients who are treatment Naïve.

View More »

GSK Investigational Site
Anaheim California 92804

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Novartis Investigative Site
Bakersfield California 93301

A clinical research study of DEB025 and RBV for the treatment of Hepatitis C, Liver Disease

Site Reference ID/Investigator# 126569
Bakersfield California 93301

Patients are needed to participate in a clinical research study evaluating ABT-450/r/ABT-267, ABT-333 and Ribavirin (RBV) for the treatment of Chronic Hepatitis C Virus (HCV) Infection Genotype 1

Site Reference ID/Investigator# 103524
Bakersfield California 93301

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Bakersfield California
Updated

Patients are needed to participate in a clinical research study of No intervention to evaluate Hepatitis C Virus

Franco Felizarta, MD
Bakersfield California 93301
Updated

Patients are needed to participate in a clinical research study to evaluate Hepatitis C

Site Reference ID/Investigator# 95580
Beverly Hills California 90211

A Phase 3 clinical study for patients with Hepatitis C, HIV Infection, Chronic Hepatitis C or Compensated Cirrhosis and Non-cirrhotics

AHF Research Center
Beverly Hills California 90211

A Phase 3 clinical study for patients with HIV or HBV

Beverly Hills California
Updated

Patients are needed to participate in a clinical research study of No intervention to evaluate Hepatitis C Virus

Sharp Coronado Hospital
Coronado California 92118
Updated

A clinical trial to evaluate treatments using ELAD treatment and Standard of care (Control) for patients with Acute Alcoholic Hepatitis

Site Reference ID/Investigator# 103530
Coronado California 92118

Patients are needed to participate in a clinical research study of ABT-450/ritonavir, ABT-333 and ABT-267 to evaluate Hepatitis C

Costa Mesa California

Patients are needed to participate in a clinical research study of GS-9857 and Placebo to match GS-9857 to evaluate Hepatitis C Virus Infection

GSK Investigational Site
Daly City California 94015

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

GSK Investigational Site
Fresno California 93726

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

Advanced Rx Clinical Research
Garden Grove California 92843

Patients are needed to participate in a clinical research study for the treatment of Hepatitis B, Chronic

GSK Investigational Site
Hayward California 94545

Study to Determine the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals; Infanrix Hexa at 2, 4 and 6 Months of Age in Healthy Infants

First 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  ... Last